Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Vaccination schedule for children in Pakistan_
| Age of vaccine administration | Name of vaccine |
|---|---|
| Immediate after birth | 1. BCG |
| 2. OPV | |
| 3. Hepatitis-B | |
| After 6 weeks | 1. OPV-1 |
| 2. Penta-1 | |
| 3. Pneumo-1 | |
| After 10 weeks | 1. OPV-2 |
| 2. Penta-2 | |
| 3. Pneumo-2 | |
| After 14 weeks | 1. OPV-3 |
| 2. Penta-3 | |
| 3. Pneumo-3 | |
| 4. IPV | |
| After 9 months | Measles-1 |
| After 15 months | Measles-2 |
Demographic and related data of the patients_
| Parameters | Patient |
|---|---|
| Patient-related | |
| Total Number | 100 |
| Male | 48 (48%) |
| Female | 52 (52%) |
| Age-wise (in months) | |
| Male | 15.06 (± 9.42) |
| Female | 15.94 (± 9.42) |
| Feeding history (%) | |
| Breastfeed | 56% |
| Formula feed | 32% |
| Breast + Formula | 12% |
| Measles vaccination status (%) | |
| Vaccinated (Total) | 24% |
| < 12 months | (n = 2) |
| 12–24 months | (n = 17) |
| > 24 months | (n = 5) |
| Unvaccinated (Total) | 76% |
| < 12 months | (n = 42) |
| 12–24 months | (n = 23) |
| > 24 months | (n = 11) |
| Vitamin A intake (both genders) | 58% |
| Parents-related | |
| Socio-economic status (%) | |
| High (≥ $4,301 per annum) | 12% |
| Middle (≥ $1,701 and ≤ $4,300 per annum) | 38% |
| Lower (≤ $1,700 per annum) | 50% |
| Educational status (%) | |
| Higher | 7% |
| Secondary | 28% |
| Primary | 22% |
| Uneducated | 43% |
Frequency and distribution of measles complications in different age groups of patients
| Clinical complications | Age-wise distribution | |||
|---|---|---|---|---|
| < 12 months | 12–24 months | > 24 months | Total | |
| Pneumonia | 23 (47.9%) | 15 (37.5%) | 3 (25%) | 41 |
| LRTI | 8 (16.7) | 8 (20)% | 2 (16.7%) | 18 |
| Otitis media | – | 1 (2.5%) | 1 (8.3%) | 2 |
| Acute diarrhea | 4 (8.3%) | 1 (2.5%) | 1 (8.3%) | 6 |
| Diarrhea + LRTI* | 6 (12.5%) | 8 (20%) | 3 (25%) | 17 |
| Pneumonia + Diarrhea | 3 (6.25%) | 2 (5%) | 1 (8.3%) | 6 |
| Otitis media + Pneumonia | 2 (4.1%) | 1 (2.5%) | 1 (8.3%) | 4 |
| Myocarditis + LRTI | 1 (2.0%) | 2 (5%) | – | 3 |
| SSPE † | – | 1 (2.5%) | – | 1 |
| Pneumothorax | 1 (2.0%) | 1 (2.5%) | – | 2 |
| Total | 48 | 40 | 12 | 100 |